Early Endoscopy Is Associated with Better Clinical Outcomes in Patients Hospitalized with Ischemic Bowel Disease
- 37 Downloads
Background and Aims
Providing diagnostic and therapeutic interventions, lower gastrointestinal endoscopy is a salient investigative modality for ischemic bowel disease (IB). As studies on the role of endoscopic timing on the outcomes of IB are lacking, we sought to clarify this association.
After identifying 18-to-90-year-old patients with a primary diagnosis of IB from the 2012–2014 Healthcare Cost and Utilization Project-Nationwide Inpatient Sample, we grouped them based on timing of endoscopy into three: early (n = 9268), late (n = 3515), and no endoscopy (n = 18,452). We explored the determinants of receiving early endoscopy, the impact of endoscopic timing on outcomes (mortality and 13 others), and the impact of the type of endoscopy (colonoscopy vs. sigmoidoscopy) on these outcomes among the early group (SAS 9.4).
Less likely to receive early endoscopy were Blacks compared to Whites (adjusted odds ratio [aOR] 0.81 95% CI [0.70–0.94]), and individuals on Medicaid, Medicare, and uninsured compared to the privately insured group (aOR 0.80 [0.71–0.91], 0.70 [0.58–0.84], and 0.68 [0.56–0.83]). Compared to the late and no endoscopy groups, patients with early endoscopy had less mortality (aOR 0.53 [0.35–0.80] and 0.09 [0.07–0.12]), shorter length of stay (LOS, 4.64 [4.43–4.87] days vs. 8.87 [8.40–9.37] and 6.62 [6.52–7.13] days), lower total hospital cost (THC, $41,055 [$37,995–$44,361] vs. $72,598 [$66,768–$78,937] and $68,737 [$64,028–$73,793]), and better outcomes. Similarly, among those who received early endoscopy, colonoscopy had better outcomes than sigmoidoscopy for mortality, THC, LOS, and adverse events.
Early endoscopy, especially colonoscopy, is associated with better clinical outcomes and decreased healthcare utilization in IB. Unfortunately, there are disparities against Blacks, and non-privately insured individuals in receiving early endoscopy.
KeywordsEndoscopy Ischemic bowel disease Health outcomes Mortality Cost Length of stay
Ischemic bowel disease
Acute kidney injury
Length of stay
Total hospital cost
Total parenteral nutrition
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 9.Baixauli J, Kiran RP, Delaney CP. Investigation and management of ischemic colitis. Cleve Clin J Med. 2003;70:920–921, 925–926, 928–930 passim.Google Scholar
- 12.Chang L, Kahler KH, Sarawate C, Quimbo R, Kralstein J. Assessment of potential risk factors associated with ischaemic colitis. Neurogastroenterol Motil. 2008;20:36–42.Google Scholar
- 17.Hale JJ, Thompson DM, Darden PM. Calculating subset weighted analysis using PROC SURVEYFREQ and GENMOD. http://support.sas.com/resources/papers/proceedings13/272-2013.pdf. Accessed 23 Dec 2017.
- 18.HCUP Methods Series Calculating National Inpatient Sample (NIS) Variances for Data Years 2012 and Later. https://www.hcup-us.ahrq.gov/reports/methods/2015_09.jsp. Accessed 21 Dec 2017.
- 31.Ryoo S-B, Oh H-K, Ha H-K, Moon SH, Choe EK, Park KJ. The outcomes and prognostic factors of surgical treatment for ischemic colitis: what can we do for a better outcome? Hepatogastroenterology. 2014;61:336–342.Google Scholar